SystImmune, Inc. Announces the Presentation of Breast Cancer Clinical Trial Results at the 2023 San Antonio Breast Cancer Conference and US Clinical Trial Developments
REDMOND, Wash., Dec. 5, 2023 /PRNewswire/ — SystImmune, Inc (SystImmune), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) authorized the company to proceed with the planned clinical study of the HER2-specific HIRE platform ADC, BL-M07D1, i
Ransomware Dwell Time Hits Low of 24 Hours
Analysis from Secureworks annual State of The Threat Report shows ransomware median dwell time has dropped from 4.5 days to less than 24 hours in a year ATLANTA, Dec. 6, 2023 /PRNewswire/ — Ransomware is being deployed within one day of initial access in more than 50% of engagements, says Secu
Aitomatic Spearheads AI Revolution in $25T Industrial Economy, Releases OpenSSA as Inaugural Member of AI Alliance with IBM & Meta
PALO ALTO, Calif., Dec. 5, 2023 /PRNewswire/ — In a landmark initiative poised to transform the $25 trillion industrial economy, Aitomatic announces its role as an inaugural member of the AI Alliance with IBM and Meta. The company is launching OpenSSA (Small Specialist Agents), a pioneering mo
Western Europe $1 Trillion Food Market Opportunities, Trends, Growth Analysis and Forecast to 2027
DUBLIN, Dec. 5, 2023 /PRNewswire/ — The “Western Europe Food Market Opportunities, Trends, Growth Analysis and Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Western Europe food industry was valued at $1 trillion in 2022. The region wi
FP Markets Awarded FX Broker Licence in Kenya by the Capital Markets Authority (CMA)
FP Markets granted second African regulation to further expand its regulatory footprint in Africa. SYDNEY, Dec. 5, 2023 /PRNewswire/ — In a move that further reinforces its position as a truly global online Forex and CFDs broker, FP Markets has announced that it has been granted a non-dea
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
ROCKVILLE, Md. and SUZHOU, China, Dec. 6, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, o
Sony Marketing Inc. teams with Cinionic to bring Barco laser to cinemas in Japan
Enabling the transition to laser with Barco Series 4 projectors in 232 screens at TOHO Cinemas by the end of February 2024 KORTRIJK, Belgium, Dec. 5, 2023 /PRNewswire/ — Cinionic, a Barco company and global leader in laser cinema, announced today that it has teamed up with Sony M
Smithfield Foods to End Grower Contracts in Utah
Utah Measures Latest Action to Address Sustained Hog Market Downturn SMITHFIELD, Va., Dec. 5, 2023 /PRNewswire/ — Smithfield Foods will end contracts with 26 hog farms in Utah to optimize its supply chain for more efficient operations in the face of an industry oversupply of pork, weaker consu
Bit Digital, Inc. Announces Monthly Production Update for November 2023
NEW YORK, Dec. 5, 2023 /PRNewswire/ — Bit Digital, Inc. (Nasdaq: BTBT) (“Bit Digital” or the “Company”), a sustainable platform for digital assets and artificial intelligence (“AI”) infrastructure headquartered in New York, announced its unaudited digital as
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
SYDNEY, Dec. 5, 2023 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA) (“Kazia” or the “Company”), an oncology-focused drug development company, today announced the closing of its previously announced purchase and sale of up to an aggregate of 4,444,445 of the Co
